| Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer D Ramirez, A Gupta, D Canter, B Harrow, RW Dobbs, V Kucherov, ... BJU international 117 (5), 783-786, 2016 | 130 | 2016 |
| A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer P Tang, H Chen, M Uhlman, YR Lin, XR Deng, B Wang, WJ Yang, KJ Xie Asian journal of andrology 15 (1), 129, 2013 | 51 | 2013 |
| Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence? MA Uhlman, L Sun, DA Stackhouse, AA Caire, TJ Polascik, CN Robertson, ... Urology 75 (2), 460-466, 2010 | 38 | 2010 |
| Baseline PSA as a predictor of prostate cancer‐specific mortality over the past 2 decades: Duke university experience P Tang, L Sun, MA Uhlman, TJ Polascik, SJ Freedland, JW Moul Cancer 116 (20), 4711-4717, 2010 | 36 | 2010 |
| Improving access to urologic care for rural populations through outreach clinics MA Uhlman, TS Gruca, R Tracy, MT Bing, BA Erickson Urology 82 (6), 1272-1276, 2013 | 35 | 2013 |
| Prostate volume as an independent predictor of prostate cancer in men with PSA of 10–50 ng ml− 1 P Tang, XL Jin, M Uhlman, YR Lin, XR Deng, B Wang, KJ Xie Asian Journal of Andrology 15 (3), 409, 2013 | 32 | 2013 |
| Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk P Tang, L Sun, MA Uhlman, CN Robertson, TJ Polascik, DM Albala, ... The Journal of urology 183 (3), 946-951, 2010 | 30 | 2010 |
| PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5–10.0 ng ml-1 and 10.1–20.0 ng ml-1: a multicenter study YR Lin, XH Wei, M Uhlman, XT Lin, SF Wu, PF Diao, HQ Xie, KJ Xie, ... Asian journal of andrology 17 (3), 503-507, 2015 | 25 | 2015 |
| Percent free prostate-specific antigen does not improve the effectiveness of prostate cancer detection in Chinese men with a prostate-specific antigen of 2.5–20.0 ng/ml: a … M Huang, Y Lin, A Xu, M Uhlman, X Deng, X Lin, S Wu, P Diao, K Xie, ... Medical oncology 31, 1-7, 2014 | 23 | 2014 |
| Novel use of AngioVac system to prevent pulmonary embolism during radical nephrectomy with inferior vena cava thrombectomy RJ Brown, MA Uhlman, JD Fernandez, T Collins, JA Brown Current urology 7 (1), 34-36, 2013 | 21 | 2013 |
| Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy MA Moriarty, MA Uhlman, MT Bing, MA O’Donnell, JA Brown, CR Tracy, ... BMC urology 15, 1-6, 2015 | 19 | 2015 |
| Variations in the open market costs for prostate cancer surgery: a survey of US hospitals SC Pate, MA Uhlman, JA Rosenthal, P Cram, BA Erickson Urology 83 (3), 626-631, 2014 | 18 | 2014 |
| Prostate cancer vaccines in combination with additional treatment modalities MA Uhlman, MT Bing, DM Lubaroff Immunologic research 59, 236-242, 2014 | 17 | 2014 |
| Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate MA Uhlman, L Sun, DA Stackhouse, TJ Polascik, V Mouraviev, ... The Journal of urology 183 (3), 997-1002, 2010 | 14 | 2010 |
| Basal cell carcinoma of the penis: a case report and review of the literature RJ Roewe, MA Uhlman, NA Bockholt, A Gupta Case Reports in Urology 2014, 2014 | 12 | 2014 |
| Explosive growth of a renal tumor during active surveillance MA Uhlman, SC Pate, JA Brown Can J Urol 20 (2), 6739-6741, 2013 | 11 | 2013 |
| Prostate-specific antigen–based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men P Tang, L Sun, MA Uhlman, CN Robertson, TJ Polascik, DM Albala, ... Urology 76 (5), 1058-1062, 2010 | 11 | 2010 |
| An update in the treatment of male urinary incontinence MT Bing, MA Uhlman, KJ Kreder Current opinion in urology 23 (6), 540-544, 2013 | 10 | 2013 |
| Risk stratification in the hormonal treatment of patients with prostate cancer MA Uhlman, JW Moul, P Tang, DA Stackhouse, L Sun Therapeutic Advances in Medical Oncology 1 (2), 79-94, 2009 | 8 | 2009 |
| Plasma proteasomal chymotrypsin-like activity correlates with prostate cancer progression X Deng, P Zhou, X Wei, M Uhlman, Y Lin, X Lin, S Wu, P Diao, H Xie, J Liu, ... Tumor Biology 36, 4115-4121, 2015 | 7 | 2015 |
